<DOC>
	<DOCNO>NCT02377934</DOCNO>
	<brief_summary>In radiotherapeutic treatment lung cancer , dose safely apply tumour limit risk radiation induce lung damage . This damage characterize parenchymal damage vascular damage . In rat , find radiation-induced vascular damage result increase pulmonary artery pressure . Interestingly , consequent loss pulmonary function could fully explain increase pulmonary artery pressure . We hypothesize also patient radiation induce increase pulmonary artery pressure observe radiotherapy , may contribute development radiation pneumonitis . The objective test hypothesis radiotherapy lung cancer induces increase pulmonary artery pressure .</brief_summary>
	<brief_title>Evaluation Radiation Induced Pulmonary Hypertension Using MRI Stage III NSCLC Patients Treated With Chemoradiotherapy . A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Age â‰¥ 18 year WHO PS 02 Histological cytological confirmation nonsmall cell lung cancer 18FFDGpositive , grow mass CTthorax suggestive NSCLC . Stage IIIA IIIB Patients extensive mediastinal lymph node involvement ( N3 ) , large primary tumour size Adequate pulmonary function estimate flow volume curve Life expectancy least 6 month Absence psychological , familial , sociological geographical condition potentially hamper compliance study protocol ; condition discuss patient registration trial . Planned 25 x 2.4 Gy , concomitant chemotherapy Before patient registration , write informed consent obtain . Presence contraindication undergo MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Cardiac MRT</keyword>
	<keyword>Radiotherapy</keyword>
</DOC>